Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically significant sustained duration of effect…
PARIS, March 10, 2026 /PRNewswire/ -- The 32nd Artprice Annual Report – 'The Art Market in 2025' – offers a…
Report maps India AI and deep tech investment surge and next wave of ecosystem funding priorities.Total IDTA Capital Commitments Now…
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…
93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…
CHARLOTTESVILLE, Va. and SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company…
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or…
JOHANNESBURG, Aug. 21, 2025 /PRNewswire/ -- On August 20, two Chery TIGGO9 flagship SUVs performed a 50% offset frontal collision test…
adidas unveils a film that positions competition as a positive aspect of sport, one that can both push individual performance…